Thomas Mohr

Medicin og biovidenskab

1. Critical Illness 100%
2. Induced Hypothermia 78%
3. Intensive Care Units 77%
4. Coronavirus 69%
5. Sepsis 61%
6. Procalcitonin 54%
7. Denmark 52%
8. Mortality 45%
9. Septic Shock 40%
10. Biomarkers 40%
11. Observational Studies 36%
12. Cohort Studies 34%
13. Randomized Controlled Trials 34%
14. Critical Care 33%
15. Respiratory Insufficiency 33%
16. 6-chloropenicillanic acid S-sulfoxide 30%
17. Anti-Bacterial Agents 27%
18. Artificial Respiration 27%
19. Survival 24%
20. Infections 24%
21. Cefuroxime 20%
22. Mechanical Ventilators 20%
23. Tazobactam Drug Combination Piperacillin 20%
24. Confidence Intervals 20%
25. Pulmonary Surfactant-Associated Protein D 20%
26. Out-of-Hospital Cardiac Arrest 20%
27. Meropenem 19%
28. Population 18%
29. Ciprofloxacin 16%
30. Thrombomodulin 16%
31. Candida 16%
32. Thrombocytopenia 14%
33. Syndecan-1 14%
34. Atrial Fibrillation 14%
35. Hydrocortisone 13%
36. C-Reactive Protein 13%
37. Renal Insufficiency 13%
38. Patient Care 13%
39. Hemorrhage 13%
40. Cardiac Arrhythmias 13%
41. Heart Arrest 13%
42. Latent Class Analysis 13%
43. Hypothermia 13%
44. Adrenal Cortex Hormones 12%
45. Leukocytes 12%
46. Hypoxia 12%
47. Pandemics 12%
48. Blood Platelets 12%
49. Length of Stay 11%
50. Comorbidity 11%